Skip to main content
Back to General Catalyst

General Catalyst's Life Science Portfolio

Browse 15 Life Science companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Life Science Companies
15
Total Funding in Life Science
$1.4B

Life Science Portfolio Companies (15)

Export
BiotechnologyHealth CareLife ScienceMedicalTherapeutics

CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.

Toronto, Canada
September 2024
$9.1M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Health CareLife SciencePersonal HealthPharmaceutical

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.

New York, United States
September 2021
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceMedical Device

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

San Diego, United States
July 2024
$74.0M
Series D

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Foundational AIHealth CareLife Science

Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design.

San Francisco, United States
July 2026
$400.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.

Cambridge, United States
May 2023
Non-equity Assistance

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
$250.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
$15K
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Hayward, United States
February 2025
$350.7M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Boston, United States
September 2025
$59.1M
Series D

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Life ScienceSoftware

Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.

Cambridge, United States
March 2025
$200.0M
Seed

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Clinical TrialsLife SciencePrecision Medicine

OASYS NOW is a medtech start-up that uses AI to optimize clinical trial recruitment, advancing precision medicine accessibility.

Delft, The Netherlands
November 2024
$1.0M
Seed

Founder Contacts

41,000+ verified contacts

Intelligent SystemsLife ScienceNeuroscience

Kernel is a neuroscience company that specializes in developing brain-recording technologies.

Los Angeles, United States
December 2023
$5.2M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London, United Kingdom
April 2023
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science

Athelas develops technology to monitor chronically ill patients in their homes.

Mountain View, United States
January 2022
Series C

Founder Contacts

41,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio